Intel is poised to propose the sale of its Altera unit and a freeze on its $30 billion German facility at an upcoming board meeting. However, the company will retain its chip manufacturing business as it navigates financial pressures and prepares for a critical turnaround.
Intel Faces Critical September Board Meeting Amid Investor Concerns, Plans Altera Sale and German Facility Freeze
In recent quarters, Intel investors have been confronted with whether this is the bottom. Unfortunately, the response has been negative, and investors are again depending on a critical board meeting in September to suspend Intel's ongoing decline and initiate a sustainable recovery, as the company's market capitalization has fallen below the significant $100 billion threshold.
Bloomberg reported on August 30 that Intel was collaborating with numerous financial advisers, including Morgan Stanley, to develop strategic options for the forthcoming board meeting. This was the initial indication of a significant revival plan. These advisers are also helping Intel defend against a high-profile attack from activist investors still dissatisfied with the company's current turmoil.
Intel intends to propose the sale of its FPGA unit Altera at the forthcoming board meeting, as per the most recent reporting by Reuters. The company cites a need for more intrinsic profits to support Altera's operations. A construction freeze on Intel's $30 billion facility in Germany is another option currently being considered. This aligns with the company's plan to reduce capital expenditure by 17 percent in 2025 to $21.5 billion.
At the board meeting, Reuters reported that Intel would not propose selling its chip manufacturing division. This item is particularly noteworthy. This is a reasonable response, as Intel has been granted billions of dollars in federal funding to establish a substantial manufacturing presence in the United States, complicating any prospective divestment strategy.
Intel's Focus on Foundry Unit Faces Challenges Amid Lip-Bu Tan's Resignation Over Innovation Stalemate
Intel is currently emphasizing its Foundry unit to foster margin expansion. By 2030, the company expects that the continuous expansion of this unit will result in cost savings of "more than $8 billion to $10 billion exiting 2025," potentially attaining a non-GAAP gross margin of approximately 60 percent and non-GAAP operating margins of roughly 40 percent.
Despite these endeavors, Intel may be compelled to contemplate the divestment of its semiconductor manufacturing unit due to the obstacles it is currently encountering.
According to Wccftech, this week, it was reported that Lip-Bu Tan, a prominent board member of Intel, has resigned. Tan attributed the board's unwillingness to adopt his proposals for transforming Intel's contract manufacturing business into a more customer-centric entity and reducing the bureaucracy, which he sees as a hindrance to innovation in the company's desktop and server divisions. This bureaucracy includes an excessive number of middle managers.


Samsung Electronics Shares Jump on HBM4 Mass Production Report
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 



